Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cardiovascular Research

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/cvr/cvp414PMID 20035032
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo

  2009cited by this paper
• The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

  2008cited by this paper
• The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis.

  2008cited by this paper
• The failing heart--an engine out of fuel.

  2007cited by this paper
• Fatty acid oxidation in cardiac and skeletal muscle mitochondria is unaffected by deletion of CD36.

  2007cited by this paper
• Metabolic mechanisms in heart failure.

  2007cited by this paper
• Determinants of left ventricular mass in hypertensive heart disease: a complex interplay between volume, pressure, systolic function and genes.

  2007cited by this paper
• Imaging of myocardial fatty acid metabolism with PET

  2007cited by this paper
• Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.

  2006cited by this paper
• Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction

  2006cited by this paper
• Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year.

  2005cited by this paper
• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio

  2005cited by this paper
• Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure?

  2005cited by this paper
• Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

  2005cited by this paper
• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

  2005cited by this paper
• Quantitative data on the afterload dependence of left ventricular dP/dtmax in isolated canine hearts

  2005cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Mitochondrial energy metabolism in heart failure: a question of balance.

  2005cited by this paper
• Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure

  2005cited by this paper
• Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation.

  2004cited by this paper
• Echocardiographic assessment of global ventricular function using the myocardial performance index in rats with hypertrophy.

  2004cited by this paper
• A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts.

  2004cited by this paper
• Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction.

  2004cited by this paper
• Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.

  2004cited by this paper
• Insulin addition after ischemia improves recovery of function equal to ischemic preconditioning in rat heart

  2003cited by this paper
• Experimental model for heart failure in rats--induction and diagnosis.

  2003cited by this paper
• Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

  2002cited by this paper
• Switching Metabolic Genes to Build a Better Heart

  2002cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure

  2002cited by this paper
• Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria.

  2002cited by this paper
• Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

  2002cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-alpha in Pacing-Induced Heart Failure

  2002cited by this paper
• Prognostic implications of left ventricular hypertrophy.

  2001cited by this paper
• Echocardiographic criteria for detection of postinfarction congestive heart failure in rats.

  2000cited by this paper
• Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

  1999cited by this paper
• Complexities underlying the quantitative determination of myocardial glucose uptake with 2-deoxyglucose.

  1998cited by this paper
• Glucose and glycogen utilisation in myocardial ischemia - changes in metabolism and consequences for the myocyte

  1998cited by this paper
• Fasting, lactate, and insulin improve ischemia tolerance in rat heart: a comparison with ischemic preconditioning.

  1996cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure.

  1987cited by this paper
• Utilization of energy-providing substrates in the isolated working rat heart.

  1980influential reference
• Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle.

  1977cited by this paper
• Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy.

  1976cited by this paper
• Carnitine palmitoyltransferase in bovine fetal heart mitochondria.

  1975cited by this paper
• [7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios

  1967cited by this paper
• Respiratory enzymes in oxidative phosphorylation. II. Difference spectra.

  1955cited by this paper
• Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization.

  1955cited by this paper

• The early metabolic cardiac targets of empagliflozin during the development of heart failure, independent of SGLT2 inhibition.

  2026cites this paper
• Pharmacological Insights into Traditional Chinese Medicine for Heart Failure: Targeting Cardiac Energy Metabolism and Mitochondrial Function

  2026cites this paper
• Therapeutic potential and mechanisms of traditional Chinese medicine in regulating energy metabolism imbalance in heart failure

  2025cites this paper
• Cardiac intermediary metabolism in heart failure: substrate use, signalling roles and therapeutic targets

  2025cites this paper
• NNT deficiency alters cardiac structure and function without impairing mitochondrial bioenergetics in aged mice

  2025cites this paper
• Pyruvate plus uridine augment mitochondrial respiration and prevent cardiac hypertrophy in zebrafish and H9c2 cells.

  2025cites this paper
• Mitochondrial Dysfunction in the Cardiovascular Disease Continuum: Problems of Studying the Progression During the Follow-Up of the Pathologies

  2025cites this paper
• Heart-brain synchrony: Therapeutic implications for neurodegenerative disease.

  2025cites this paper
• Succinate-driven PKM2 succinylation and dimerization accelerates age-associated cardiac fibrosis.

  2025cites this paper
• Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation.

  2024cites this paper
• Effect of His Bundle Pacing on Abnormal Myocardial Fatty Acid and Glucose Metabolism Induced by Right Ventricular Pacing

  2024cites this paper
• Heart–brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential

  2024cites this paper
• (Myocardium Remodelling: From Adaptation Mechanisms to Heart Failure Development)

  2024cites this paper
• Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole

  2024cites this paper
• Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Elevated Na is a dynamic and reversible modulator of mitochondrial metabolism in the heart

  2024cites this paper
• Hypoxia-Inducible Factor 1-Alpha and Glucose Metabolism during Cardiac Remodeling Progression from Hypertrophy to Heart Failure

  2023cites this paper
• Integrated Control of Fatty Acid Metabolism in Heart Failure

  2023cites this paper
• The treatment of chronic anemia in heart failure: a global approach

  2023cites this paper
• Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

  2023cites this paper
• The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure

  2023influential citation
• Metabolic medicine: The mechanism of metabolic influence on diseases of various systems

  2023cites this paper
• SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism

  2023cites this paper
• Targeting Mitochondrial Metabolism to Save the Failing Heart

  2023cites this paper
• Effects of early exercise on cardiac function and lipid metabolism pathway in heart failure

  2023influential citation
• Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling

  2023cites this paper
• Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

  2023cites this paper
• Comprehensive Analysis of Mitochondrial Dynamics Alterations in Heart Diseases

  2023cites this paper
• High-dimensional proteomics identifies organ injury patterns associated with outcomes in human trauma

  2023cites this paper
• Empagliflozin improves cardiac energetics during ischaemia/reperfusion by directly increasing cardiac ketone utilization

  2023cites this paper
• The KLF7/PFKL/ACADL axis modulates cardiac metabolic remodelling during cardiac hypertrophy in male mice

  2023cites this paper
• Molecular mechanisms underlying sarcopenia in heart failure

  2023cites this paper
• PCSK9: A emerging participant in heart failure.

  2022cites this paper
• Iron Deficiency and Deranged Myocardial Energetics in Heart Failure

  2022cites this paper
• Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

  2022cites this paper
• Heart Failure and Drug Therapies: A Metabolic Review

  2022cites this paper
• A mitochondrial long-chain fatty acid oxidation defect leads to tRNA uncharging and activation of the integrated stress response in the mouse heart.

  2022cites this paper
• Regulation of the Keap1-Nrf2 Signaling Axis by Glycyrrhetinic Acid Promoted Oxidative Stress-Induced H9C2 Cell Apoptosis

  2022cites this paper
• Changes of Plasma Tris(hydroxymethyl)aminomethane and 5-Guanidino-3-methyl-2-oxopentanoic Acid as Biomarkers of Heart Remodeling after Left Ventricular Assist Device Support

  2022cites this paper
• PERM1 regulates energy metabolism in the heart via ERRα/PGC−1α axis

  2022cites this paper
• Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

  2022cites this paper
• Inefficient Batteries in Heart Failure

  2022cites this paper
• The regulation of cardiac intermediary metabolism by NADPH oxidases

  2022cites this paper
• Traditional Chinese medicine enhances myocardial metabolism during heart failure.

  2021cites this paper
• Cardiac Specific Overexpression of Transcription Factor EB (TFEB) in Normal Hearts Induces Pathologic Cardiac Hypertrophy and Lethal Cardiomyopathy

  2021cites this paper
• PHDs/CPT1B/VDAC1 axis regulates long-chain fatty acid oxidation in cardiomyocytes

  2021cites this paper
• Metabolic Remodeling and Implicated Calcium and Signal Transduction Pathways in the Pathogenesis of Heart Failure

  2021influential citation
• Development of a PET/MRI exercise stress test for determining cardiac glucose dependence in pulmonary arterial hypertension

  2021cites this paper
• Left Atrial Remodeling Mechanisms Associated with Atrial Fibrillation

  2021cites this paper
• Water-soluble alkaloids extracted from Aconiti Radix lateralis praeparata protect against chronic heart failure in rats via a calcium signaling pathway.

  2021cites this paper
• Regulation of Mitochondrial Function by Noncoding RNAs in Heart Failure and Its Application in Diagnosis and Treatment

  2021cites this paper
• Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets

  2021cites this paper
• Changes in Expressions of HSP27, HSP70, and Soluble Glycoprotein in Heart Failure Rats Complicated with Pulmonary Edema and Correlations with Cardiopulmonary Functions

  2021cites this paper
• Systemic Bioinformatic Analyses of Nuclear-Encoded Mitochondrial Genes in Hypertrophic Cardiomyopathy

  2021cites this paper
• The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It’s Not All Bad

  2021cites this paper
• Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

  2021cites this paper
• Narrative review of metabolomics in cardiovascular disease

  2021cites this paper
• Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis

  2021cites this paper
• Mitochondrial Bioenergetics and Dynamism in the Failing Heart

  2021influential citation
• Cardiac substrate utilization in heart failure: Where is the relevance of SGLT2 inhibition?

  2021cites this paper
• Modulations of Cardiac Functions and Pathogenesis by Reactive Oxygen Species and Natural Antioxidants

  2021cites this paper
• Cardiac Left Ventricle Mitochondrial Dysfunction After Neonatal Exposure to Hyperoxia: Relevance for Cardiomyopathy After Preterm Birth

  2021cites this paper
• Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

  2021cites this paper
• Left Ventricular Reverse Remodeling in Heart Failure: Remission to Recovery

  2021cites this paper
• Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure

  2021cites this paper
• Mitochondrial Dysfunction and Mitochondrial Therapies in Heart Failure.

  2021cites this paper
• Metabolic Therapy of Heart Failure: Is There a Future for B Vitamins?

  2021cites this paper
• Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling

  2020cites this paper
• Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review

  2020cites this paper
• Mitochondrial Pathobiology and Metabolic Remodeling in Progression to Overt Systolic Heart Failure

  2020cites this paper
• Mechanisms Underlying Development of Taurine-Deficient Cardiomyopathy

  2020cites this paper
• Substrate metabolism regulated by Sestrin2–mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart

  2020cites this paper
• Caloric restriction in heart failure: A systematic review.

  2020cites this paper
• Lipid in the midst of metabolic remodeling - Therapeutic implications for the failing heart.

  2020cites this paper
• [Focus on the Myocardial Hypertrophy from the Perspective of Transcriptomics and Metabolomics].

  2020cites this paper
• Increasing carbohydrate oxidation improves contractile reserves and prevents hypertrophy in porcine right heart failure

  2020cites this paper
• Impaired Myocardial Energetics Causes Mechanical Dysfunction in Decompensated Failing Hearts

  2020cites this paper
• Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice

  2020cites this paper
• Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure.

  2020cites this paper
• Ketogenic Diet Prevents Heart Failure from Defective Mitochondrial Pyruvate Metabolism

  2020cites this paper
• Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.

  2020cites this paper
• Multiple Levels of PGC-1α Dysregulation in Heart Failure

  2020cites this paper
• Measuring the link between cardiac mechanical function and metabolism during hyperpolarized 13C-pyruvate magnetic resonance experiments.

  2020cites this paper
• High‐fat diet affects skeletal muscle mitochondria comparable to pressure overload‐induced heart failure

  2020cites this paper
• Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts

  2019cites this paper
• Novel Concepts in Cardiac Energy Metabolism: From Biology to Disease

  2019cites this paper
• Lin28a Regulates Pathological Cardiac Hypertrophic Growth through Pck2‐mediated Enhancement of Anabolic Synthesis

  2019cites this paper
• Sex Specific Mechanisms of Myocardial Hypertrophy and Heart Failure

  2019cites this paper
• Mitochondrial Dysfunction as Substrate for Arrhythmogenic Cardiomyopathy: A Search for New Disease Mechanisms

  2019cites this paper
• Activation of Cannabinoid Receptors Attenuates Endothelin-1–Induced Mitochondrial Dysfunction in Rat Ventricular Myocytes

  2019cites this paper
• Cardiac manifestations of inherited metabolic disease linked to cellular metabolism of vitamin B12 : study in two murine models of invalidation of Mtr and MMACHC genes

  2019cites this paper
• Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart.

  2019cites this paper
• Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction

  2019cites this paper
• A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics

  2019cites this paper
• Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation.

  2019cites this paper
• Myocardial Metabolism

  2019cites this paper
• INDUCED PLURIPOTENT STEM CELLS FOR MODELLING ENERGETIC ALTERATIONS IN HYPERTROPHIC CARDIOMYOPATHY.

  2019cites this paper
• Role of YAP/TAZ in Energy Metabolism in the Heart.

  2019cites this paper
• Chronic Pressure Overload Results in Deficiency of Mitochondrial Membrane Transporter ABCB7 Which Contributes to Iron Overload, Mitochondrial Dysfunction, Metabolic Shift and Worsens Cardiac Function

  2019cites this paper